목차
1. 역사
2. HIV의 일반적 성상
3. HIV감염의 병리 및 면역학적 특성
4. HIV의 전파
5. 항체 및 바이러스 검사
6. HIV의 소득 및 주의
7. 치료제
8. 예방백신
9. 맺는 말
2. HIV의 일반적 성상
3. HIV감염의 병리 및 면역학적 특성
4. HIV의 전파
5. 항체 및 바이러스 검사
6. HIV의 소득 및 주의
7. 치료제
8. 예방백신
9. 맺는 말
본문내용
AIDS-risk patients in Britain. Lancet, 2, 477-480.
15. Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., Alizon, M.(1987). Genome organization and transactivation of the human immunodeficiency virus type 2. Nature, 326, 662-669.
16. Kornfeld, H., Riedel, N., Viglianti, G.A., Hirsch, V., Mullins, J.I.(1987). Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature, 326, 610-613, 1987.
17. Arya, S. K., Guo, C., Josephs, S.F., Wong-Staal, F.(1985). Trans-activator gene of human T-Lymphotropic virus type III(HTLV-III). Science, 229, 69-73.
18. Sodroski, J., Potarca, R., Rosen, C, Wong-Staal, F, Haseltine, W.(1985). Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science, 229, 74-77.
19. Wong-Staal, F., Shaw, G. M., Hahn, B.H., Zaki Salahuddin, S., Popovie, M., Markhan, P., Redfield, R., Gallo, R.C.(1985). Genomic diversity of human T-lymphotropic virus type III(HTLV-III). Science, 229, 759-762.
20. Lifson, J.D., et al.(1986). Induction of CD4-dependent cell fusion by the HTLV-III/ LAV envelope glycoprotein. nature, 323, 725-728.
21. 이원영(1985). 후천성 면역결핍증(AIDS)의 원인체 HTLV III/ LAV에 관하여. 한국역학 회지, 7(2), 168-176.
22. Clercq, E.D.(1986). Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome(AIDS). J. Med. Chem., 29, 1561-1569.
영문초록:
The Etiologic Agent For Acquired
Immunodeficiency Syndrome
Won-young Lee, Sc.D.
In 1981, an unusual case with immunodeficiency was reported and there after an epidemic of the similar syndrome in population of homosexuals was recognized by Center for Diseases Control(CDC) U. S. A. Later the disease was characterized as an acquired immunodeficiency syndrome(AIDS). In 1983, virologists found the causative agent which is a novel retrovirus named human immunodeficiency virus(HIV). Since then, by use of modern biotechnology, numerous and detailed informations have been accumulated by various researchers. The result, however, demonstrated that there is no single method of satisfaction to prevent of cure the disease except avoiding from the agent. This problems are discussed by reviewing the results reported up to data.
15. Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., Alizon, M.(1987). Genome organization and transactivation of the human immunodeficiency virus type 2. Nature, 326, 662-669.
16. Kornfeld, H., Riedel, N., Viglianti, G.A., Hirsch, V., Mullins, J.I.(1987). Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature, 326, 610-613, 1987.
17. Arya, S. K., Guo, C., Josephs, S.F., Wong-Staal, F.(1985). Trans-activator gene of human T-Lymphotropic virus type III(HTLV-III). Science, 229, 69-73.
18. Sodroski, J., Potarca, R., Rosen, C, Wong-Staal, F, Haseltine, W.(1985). Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science, 229, 74-77.
19. Wong-Staal, F., Shaw, G. M., Hahn, B.H., Zaki Salahuddin, S., Popovie, M., Markhan, P., Redfield, R., Gallo, R.C.(1985). Genomic diversity of human T-lymphotropic virus type III(HTLV-III). Science, 229, 759-762.
20. Lifson, J.D., et al.(1986). Induction of CD4-dependent cell fusion by the HTLV-III/ LAV envelope glycoprotein. nature, 323, 725-728.
21. 이원영(1985). 후천성 면역결핍증(AIDS)의 원인체 HTLV III/ LAV에 관하여. 한국역학 회지, 7(2), 168-176.
22. Clercq, E.D.(1986). Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome(AIDS). J. Med. Chem., 29, 1561-1569.
영문초록:
The Etiologic Agent For Acquired
Immunodeficiency Syndrome
Won-young Lee, Sc.D.
In 1981, an unusual case with immunodeficiency was reported and there after an epidemic of the similar syndrome in population of homosexuals was recognized by Center for Diseases Control(CDC) U. S. A. Later the disease was characterized as an acquired immunodeficiency syndrome(AIDS). In 1983, virologists found the causative agent which is a novel retrovirus named human immunodeficiency virus(HIV). Since then, by use of modern biotechnology, numerous and detailed informations have been accumulated by various researchers. The result, however, demonstrated that there is no single method of satisfaction to prevent of cure the disease except avoiding from the agent. This problems are discussed by reviewing the results reported up to data.
추천자료
사스에 대한 상식
세계도시 인구증가가 초래하는 문제점과 해결방안
인간배아복제에 대해 논하시오
치매의 발생원인과 예방
성병의 원인과 예방방법
동성애에 대한 나의 생각-여성학-
전염병의 정의와 종류 및 증상
구강내과학
[질병, 질병 생물학적 정의, 질병 역사, 콜레라 정의, 콜레라 감염경로와 증상, 콜레라 사례]...
[권리, 언론수용자, 장애인, 여성이주노동자, 특수고용노동자, 환자, 교사, 청소년]언론수용...
대장암과 직장암의 이해와 간호 (Colon & Rectal Cancer)
간호학과 중요 간호약어1
[사회복지실천론] 사회복지실천현장 하나를 선택하여 실천현장소개, 사회복지사 역할 및 업...